Special Issue "Advancements in Novel Nanomaterials for Cancer Therapy and Diagnosis"

Dear Colleagues,

Nanotechnology is a relatively new field with the potential to create new technology for more accurate and efficient cancer treatment and diagnosis. Nanotechnology deals with developing nanomaterials with a high surface area-to-volume ratio and possessing unique optical, magnetic, and electrical properties. Due to these properties, nanomaterials are being thoroughly researched for their potential in cancer therapy and have caught the attention of researchers worldwide. Nanotechnology utilizes a wide array of materials ranging from biological to synthetic origins, to fabricate tiny particles, which have excellent abilities in terms of physicochemical properties and is widely being studied to illustrate their biological interactions. These nanotechnology-derived products showed promising results in treating several human ailments. However, more attention is given to treating highly complicated proliferative diseases. Multiple approaches have been studied, including size-based efficiency and surface property-mediated proficiency and so on, examined to control the progression of cancer effectively. In the concept of targeting disease, passive-to-active targeting has been researched. By the time research has been extended to not just the target tumor cells, its focus on tumor microenvironment targeting has proved to have better outcomes in reducing disease. Moreover, nanotechnology-derived immunotherapy depicts an exceptional ability in suppressing cancer development; however, there is a long way to go to attain side-effect-free effective nanotoxic materials for the treatment of diverse cancer diseases.

The goal of this Special Issue is to document developments in nanomaterials for cancer therapy and diagnosis. We welcome articles involving nanoparticles targeting cancer in all aspects and invite researchers to publish their original research or review articles with expert opinions and perspectives in the above-mentioned fields.

Dr. Ponnuchamy Kumar
Dr. Puneet Khandelwal
Dr. Mariya Gover Antoniraj 
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• nanomaterials
• nanotechnology
• nanoparticles
• nanomedicine
• surface charge
• cancer
• apoptosis
• mitochondria
• immunotherapy
• tumor microenvironment
• liposomes
• lipid nanoparticles
• polymer nanoparticles
• cancer
• drug delivery
• gene delivery